CORT

#1377
Corcept Therapeutics Inc.
43.3000 USD
+3.32%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
43.3000
43.3000
Intervallo Annuale
28.6601
89.0000
Variazione giornaliera
+3.32%
Variazione Mensile
+33.81%
Variazione di 6 mesi
-40.98%
Variazione Annuale
-40.98%
Chiusura Precedente
41.9100
Apertura
43.3000
Bid
Ask
Minimo
43.3000
High
43.3000
Volume
81
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 4.606 B
  • Employee 730
  • Founded 1998
  • CEO N/A
  • Website www.corcept.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKJG33
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
42.44
Rapporto prezzo/fatturato
5.48

Corcept Therapeutics Incorporated

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Notizie